NCT01553227

Brief Summary

Sleep Apnea Hypopnea Syndrome (OSAHS), is common in patients with OHS, compared to single Obesity Hypoventilation Syndrome (OHS) or OSAHS ,patients with both of them are more susceptible to have serious hypoxia and carbon dioxide retention during sleep, and much more likely to result in pulmonary hypertension and cor-pulmonale. At present, the most widely and valid method for these patients is the Bilevel Positive Airway Pressure (BiPAP) ventilation, while, recently, the investigators discovered a completely novel device, namely auto-trilevel Ventilator. In contrast to the traditional therapy, auto-trilevel Ventilator has a more flexible expiratory positive airway pressure (EPAP), with which it can removing residual obstructive sleep apnea hypopnea events and correcting hypercapnia without contradiction. Treated with auto-trilevel ventilator may delay the progression of disease and improve life quality. The overall purpose of this study is to determine the curative effects of auto-trilevel ventilators on patients with OHS and OSAHS.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2011

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2011

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

March 8, 2012

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 14, 2012

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2012

Completed
Last Updated

November 27, 2012

Status Verified

November 1, 2012

Enrollment Period

1.3 years

First QC Date

March 8, 2012

Last Update Submit

November 26, 2012

Conditions

Keywords

OSAHS: Obstructive Sleep Apnea hypopnea SyndromeOHS: Obesity Hypoventilation SyndromeAuto-trilevel ventilationBiPAP ventilation

Outcome Measures

Primary Outcomes (1)

  • Effect of auto-trilevel ventilation on patients with OSAHS and OHS

    The overall purpose of this study is to determine the effects of auto-trilevel ventilator on patients with OSAHS and OHS. The following parameters are compared such as apnea hypopnea index, lowest SPO2, arousal index, sleep efficiency, PaCO2, daytime sleepiness and so on.

    Participants will be observed for the duration of hospital stay an expected average of 1 week

Study Arms (1)

ventilator

EXPERIMENTAL

The overall purpose of this study is to determine the effects of auto-Trilevel ventilation on patients with OSAHS and OHS by comparison with BiPAP ventilation. The following parameters are compared such as apnea hypopnea index, lowest SPO2, arousal index, sleep efficiency, PaCO2, daytime sleepiness and so on.

Device: ventilator

Interventions

Noninvasive ventilation including fixed BiPAP ventilation and auto-trilevel ventilation. Using the same IPAP, treatment include one night with BiPAP ventilation mode 1, one night with BiPAP ventilation mode 2 and one night with auto-trilevel ventilation mode. Each treatment last 8 hours for each night.

Also known as: Auto-trilevel ventilation
ventilator

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient or legal representative of the patient is willing and able to sign an approved informed consent and privacy protection authorization in the United States.
  • Subject is \>18 years old.
  • Diagnosed OHS and OSAHS:
  • Expected to tolerate the ventilator therapy.

You may not qualify if:

  • Patient is currently enrolled in another clinical study which may confound the result of this study.
  • Patient for whom inform consent cannot be obtained.
  • Patients with a history of cerebrovascular accident within the 6 months prior to this study.
  • Patients with acute or chronic renal failure, diabetes and severe lung diseases.
  • Patients with unstable angina.
  • Patient who is of pregnant or during lactation period.
  • Patients with a history of injury or surgery within 6 months prior to the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First Affiliated Hospital of Nanjing Medical University

Nanjing, Jiangsu, China

Location

MeSH Terms

Conditions

Sleep Apnea, ObstructiveObesity Hypoventilation Syndrome

Interventions

Ventilators, Mechanical

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesHypoventilationRespiratory InsufficiencyObesityOverweightOvernutritionNutrition DisordersNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Equipment and Supplies

Study Officials

  • xilong zhang, MD

    The First Affiliated Hospital with Nanjing Medical University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
The First Affiliated Hospital of Nanjing Medical University

Study Record Dates

First Submitted

March 8, 2012

First Posted

March 14, 2012

Study Start

August 1, 2011

Primary Completion

November 1, 2012

Study Completion

November 1, 2012

Last Updated

November 27, 2012

Record last verified: 2012-11

Locations